(Circulation. 1996;93:1919-1927.)
© 1996 American Heart Association, Inc.
Articles |
From the Departments of Radiological Sciences (S.M., A.E., J.T.), Medicine (Cardiology) (S.M., C.Y.L.), and Ecology and Evolutionary Biology (J.H.), University of California (Irvine).
| Abstract |
|---|
|
|
|---|
Methods and Results The left anterior descending coronary artery (LAD) of 15 anesthetized pigs (40 to 50 kg) was dissected free from the epicardium in its proximal portion, and a transit-time ultrasound flow probe of the appropriate size was applied. A vascular occluder was positioned distal to the flow probe for flow adjustments. Contrast injections (2 to 4 mL/s for 3 seconds) were made into the left main coronary artery during image acquisition with a motion-immune dual-energy digital subtraction angiography (DE DSA) system. Tissue-suppressed energy-subtracted images were used to generate time-density curves. BF measurements were made in the LAD vascular bed with use of the time-density curve, with consideration that blood was momentarily replaced with contrast during the injection. In 19 comparisons, the mean BF, measured with the use of DE DSA, correlated extremely well with the mean ultrasound flow (DE DSA=0.90 ultrasound+3.10 mL/min, r=.96). Also, contrast injection increased the BF by an average of only 15% during the image-acquisition time interval.
Conclusions Accurate BF measurements can be made with motion-immune DE DSA. The BF measurements can be completed before the onset of significant changes in BF due to contrast injection. Furthermore, it is possible to make the BF measurements during routine coronary arteriography.
Key Words: blood flow angiography coronary disease atherosclerosis imaging
| Introduction |
|---|
|
|
|---|
Because of the major limitations of standard cineangiography, a functional measure of stenosis severity, such as measurement of coronary blood flow, that is obtainable during cardiac catheterization is desirable. The introduction of digital angiographic techniques provides the potential for obtaining such data during routine coronary angiography through its ability to provide physiological information in addition to the anatomic information present in the angiogram. For example, analysis of the propagation of contrast material through the circulatory system can be used to obtain measurements of physiological variables such as coronary blood flow and flow reserve.10 11
Various angiographic methods of assessing coronary arterial blood flow have been investigated. After contrast injection, blood flow is determined with the contrast pass curve data derived from the epicardial arteries or the myocardial vascular bed. The contrast pass curve data are obtained from epicardial arteries with the use of contrast dilution12 13 14 15 and contrast transit-time methods.16 17 18 However, these techniques have serious limitations, including the need to accurately determine arterial dimensions, misregistration artifacts, and the need for a high frame rate.
The flow measurement techniques based on contrast pass curve data measured in the myocardial vascular bed involve the use of mean contrast transit-time19 20 and parametric imaging methods.21 22 23 24 However, these techniques can be used only to measure relative blood flow because they quantify parameters, such as time of arrival, that are correlated only to coronary blood flow.
Techniques based on the first-pass distribution analysis (FPA) have previously been investigated for the measurement of coronary blood flow.25 26 These techniques combine videodensitometric analysis of spatial and temporal aspects concerning the contrast propagation through the myocardium. The flow measurements are made by summing pixel values in large regions of interest with the use of temporal subtraction images. The major limitations of these studies include the determination of blood iodine concentration, motion misregistration artifacts in temporal subtraction images, and nonlinearities due to physical degradation factors, such as x-ray scatter and veiling glare.
As a solution to the motion misregistration artifacts, we developed a dual-energy subtraction mode that eliminates these misregistration artifacts.27 We also developed a method to correct for nonlinearities due to x-ray scatter and veiling glare.28 29 An in vitro validation of flow measurements with the FPA algorithm and the dual-energy subtraction technique has been previously reported.30
The purpose of the present study was to achieve in vivo validation of the coronary blood flow measurement technique with FPA and a motion-immune dual-energy digital subtraction technique. In addition, we investigated the effects of contrast injection on coronary blood flow and a method for the determination of blood iodine concentration.
| Methods |
|---|
|
|
|---|
|
The system input supplies the vascular bed with blood flow at rate
Q(t). Flow into the vascular bed is measured by injecting
contrast material into the input conduit. The injection of the
iodinated contrast material results in concentration
C(t) in the blood entering the vascular bed. The
concentration C(t) is a dimensionless volume concentration
parameter that is equal to the ratio of volume of contrast
material in a volume element divided by the total volume of blood and
contrast in that element. It is assumed that there is a minimum transit
time (tmin) through the vascular bed before
which none of the contrast material exits. For times less than this
minimum system transit time, all of the contrast material entering the
vascular bed accumulates there. Therefore, the volume of contrast that
accumulates in time period
t is calculated as
![]() | (1) |
for t
tmin.
If the input arterial concentration is approximately
constant [C(t)=C] during the flow measurement, Equation 1
becomes:
![]() | (2) |
t is defined
as
![]() | (3) |
With Equations 2 and 3 combined, the following expression for
average volumetric blood flow can be obtained:
![]() | (4) |
This model makes two necessary assumptions: (1) the flow measurement is performed before the contrast begins to exit the vascular bed, and (2) the input contrast concentration is approximated by the average value C and is known during the flow measurement period.
In Equation 4
, average flow depends on the difference in contrast
material volume (
V) between two images separated by a
time period of
t and the average iodine concentration
(C). Therefore, if absolute videodensitometric measurements
of
V and C are made, the flow rate into the
vascular bed can be calculated. It is well known that, in the ideal
case, the pixel value in a logarithmically subtracted image is directly
proportional to the thickness of contrast material that is present
at that spatial location. The constant of proportionality is the
effective attenuation coefficient of iodine
µI. The volume of contrast material can
be calculated by multiplying the thickness with the pixel area.
Therefore, the contrast volume over any region is proportional to the
integrated videodensitometric iodine signal over that region of the
image. Also, the change of contrast volume in the vascular bed can be
determined with use of the change in the integrated videodensitometric
iodine signal (
DI) with the expression:
![]() | (5) |
where
DI=DI(t+
t)-DI(t),
and it represents the difference in the videodensitometric
iodine signal over the region corresponding to the vascular bed for the
time period
t. With Equations 4 and 5 combined, the
expression for the average flow rate (Q) for a
time period
t can be rewritten as:
![]() | (6) |
The attenuation coefficient of iodine
µI and the pixel area A can be
measured with the use of calibration images. The time period
t may be measured with the known acquisition frame rate.
The iodine concentration C of the bolus entering the
myocardial vascular bed is assumed to be the same as the iodine
concentration of the contrast agent. This assumption is based on the
fact that contrast is injected at a sufficiently high injection rate to
momentarily replace blood with contrast.
Animal Preparation
Fasted swine (40 to 55 kg, n=15) were sedated with acepromazine
(1.0 mg/kg IM), atropine (0.11 mL/kg IM), ketamine (20 mg/kg
IM), and zylazyne (1.0 mg/kg IM). The animals were anesthetized
with halothane (0.5% to 2.0%) and nitrous oxide (70%
N2O/30% O2) and ventilated with a Harvard
Apparatus ventilator. Ventilator settings were adjusted
during the experiments to maintain PO2 and
PCO2 within normal ranges. A
peripheral vein was used for the administration of
medication and intravenous fluid. The right femoral artery
was isolated and was used to measure the blood pressure with a
calibrated Stratham P23ID pressure transducer. A modified left
thoracotomy was performed, and the heart was suspended in a pericardial
cradle. The left anterior descending coronary artery (LAD) was
dissected free from the epicardium in its proximal portion, and a
transit-time ultrasound flow probe (Transonic Systems) of
appropriate size was applied. A vascular occluder was positioned distal
to the ultrasound probe for flow adjustments. Standard techniques were
used to cannulate the left main ostium with a 7F multipurpose
diagnostic catheter inserted through the femoral artery
under fluoroscopic guidance. An intracoronary
administration of adenosine (1 to 3 mg at 0.5 mg/mL) and the
vascular occluder were used to produce a range of coronary
blood flow. ECG, femoral artery blood pressure, LAD blood flow, and
x-ray tube voltage (kVp) were recorded continuously (Biopac
Systems). The procedures used in this study were approved by the
University of California-Irvine Animal Research Committee.
Each animal was positioned under the image intensifier, and the
projection was optimized for separation of the LAD and circumflex
vascular beds (
30° right anterior oblique). Dual-energy
coronary angiograms were then obtained after power injection of
6 to 10 mL of a nonionic iodinated contrast material
(Hexabrix, Mallinckrodt Medical) with an injection rate of 2 and 4 mL/s
for baseline and maximum hyperemia, respectively. To minimize
the effect of ventilation on angiographic acquisitions, the respirator
was turned off at the end of full expiration.
Image Acquisition and Processing
All images were acquired with the use of a conventional
x-ray tube (Dynamax 79-45/120, Machlett Laboratories), a constant
potential x-ray generator (Optimus M200, Philips Medical Systems),
a 23/15-cm CsI image intensifier, a focused grid (8:1 grid
ratio, 36 lines/cm), and a charge-coupled device camera (Multicam
MC-1134GN, Texas Instruments). Light intensity in front of the camera
was controlled with an adjustable aperture. The video signal was
linearly digitized to 512x512x8-bit precision, and the image
processing was performed with a Fischer DA-100 image processor (Fischer
Imaging).
The images were acquired with the 15-cm image intensifier mode and the large (1.2 mm nominal) focal spot. A dual-energy mode was used for image acquisition. In this mode, the low-energy beam was formed with a 60- to 70-kVp beam with 2-mm aluminum filtration. The high-energy beam was produced with an x-ray tube voltage of 110 to 120 kVp with an additional 2.5 mm of copper filtration.27 The kVp and beam filtration were switched at 30 Hz. The low- and high-energy images were separated by only 5 milliseconds.
Dual-energy images were formed with a weighted subtraction of logarithmically processed high- and low-energy images.27 Corrections were made for the spatially varying scatter- and veiling glare before logarithmic transformation. A convolution filtering technique was used to estimate scatter-glare distribution in images without the need to sample the scatter-glare intensity for each experiment.28 29 This technique involves the use of the exposure parameters and detected intensity distribution to estimate scatter-glare intensity by predicting the total thickness at every pixel in the image. The thickness information was used to estimate scatter-glare on a pixel-by-pixel basis. Corrections were also made for variation of scatter-glare fraction with beam energy and field size. The detector field nonuniformity and Heel effect were corrected by dividing the detected image with a template image, acquired without scattering material in the x-ray beam.
Flow Measurements
Flow measurements were made on tissue-suppressed
energy-subtracted images. A region of interest (ROI) was drawn
around the LAD vascular bed (Fig 2
). The ROI was drawn
sufficiently large to ensure that the vascular bed stays within the ROI
during the entire cardiac cycle. The average background signal was
estimated by drawing a narrow-strip ROI around the vascular bed.
The background-corrected videodensitometric iodine signal was used
for contrast volume calculations.
|
An iodine calibration phantom consisting of an array of cylindrical
cells 7 mm in diameter and 10 mm in depth was used to calibrate
videodensitometric iodine signal for a range of iodine thicknesses (0
to 125 mg/cm2). A typical system calibration curve is shown
in Fig 3
. As previously shown (Equation 4
), the
calibration curve and the known iodine concentration of the contrast
material can be used to convert the integrated videodensitometric
iodine signal to contrast volume. Therefore, the difference in
integrated videodensitometric iodine signal in the vascular bed can be
converted to the volume of contrast bolus entering the vascular bed
between successive images. A typical curve showing the contrast volume
accumulation in the LAD vascular bed after injection of contrast
material is shown in Fig 4
. The contrast volume
accumulation in the vascular bed and the known time period between
dual-energy images were used to generate phasic flow of contrast
into the LAD vascular bed. Mean coronary blood flow was
calculated by averaging instantaneous flow measurements over two
cardiac cycles. An example of mean coronary blood flow through
the LAD vascular bed is shown in Fig 5
. The initial
underestimation is due to the mixture of contrast and blood in the
initial segment of the contrast bolus. The underestimation at the end
is mainly due to the entrance of diluted contrast material into the
vascular bed after the end of contrast injection (injection time of 2.5
seconds). The simultaneous recording of ultrasound
flow probe data along with the kVp signal from the x-ray generator,
during image acquisition, was used to compare the flow measurements
during the same time period.
|
|
|
Effect of Contrast Injection on Blood Flow
The intracoronary injection of contrast agents has
long been recognized to produce hemodynamic effects,
which are mainly due to the physical and chemical properties of the
contrast material. The high viscosity and osmolarity relative to blood,
sodium content, and pH are some of the properties that are thought to
cause these hemodynamic effects. Therefore, it is
important to be certain that measured changes in flow are due to the
presence or absence of stenosis rather than to perturbation
caused by contrast media. Typical mean ultrasound coronary
blood flow after an injection of contrast material is shown in Fig 6
. The immediate effects of intracoronary
contrast injection on coronary blood flow have been reported
previously.31 These flow alterations occur in three
distinct phases. The first phase is the slight increase in flow during
contrast injection. The second phase is a reduction in flow, which
begins immediately after injection of the contrast material. The third
phase consists of the contrast-induced hyperemic response
that increases the flow above preinjection levels. In "Appendix,"
a physical model was used to evaluate the effects of contrast injection
on coronary artery blood flow.
|
In the present study, the measurements of blood flow were made during the contrast injection time interval. Therefore, only the initial slight increase, characterizing phase 1, affected our flow measurements. During this phase, there are two main factors that need to be considered; the minimum injection rate required for complete replacement of blood with contrast material and the change in blood flow due to contrast injection during the flow measurement time interval.
To determine the injection rate required for complete replacement of blood with contrast material, the catheter was positioned in the left coronary ostium and the injection rate was varied over the range of 0.75 to 4.0 mL/s. A small ROI was positioned on the proximal segment of the LAD in phase-matched subtracted images. The background-corrected videodensitometric signal in the ROI was converted to contrast volume with the use of the system calibration curve. The volume of contrast material enclosed in the ROI was used to generate a contrast pass curve. The maximum of the contrast pass curve was then compared for different injection rates. The minimum injection rate that produced the maximum contrast volume in the ROI was assumed to be the minimum required injection rate for complete replacement of blood with contrast material.
The perturbation in blood flow during the time period used for the FPA flow measurements was calculated with the ultrasound flow probe data. The preinjection blood flow was calculated by averaging LAD blood flow for several cardiac cycles before contrast injection. The change in blood flow was determined by comparing the preinjection blood flow with the average blood flow for the two cycles used for flow measurements with use of the FPA algorithm. Also, in vitro flow measurement was used to establish the fact that accurate flow measurements can be made with the transit-time ultrasound flow probe in the presence of pure contrast material.
| Results |
|---|
|
|
|---|
30 instantaneous flow data points). The two flow
measurements were made during the same time period; therefore, the
effect of contrast injection on coronary blood flow is
eliminated. The measured FPA algorithm (DE) and known ultrasound (US)
mean coronary blood flow rates were related by DE=0.90 US-3.10
mL/s (r=.96).
|
|
Effect of Contrast Injection on Blood Flow
An important factor in this flow-measurement technique is the
accurate determination of iodine concentration of the contrast bolus
entering the vascular bed. Therefore, it is essential to determine the
minimum required injection rate to momentarily replace blood with
contrast material. It is also necessary to determine the change in
coronary blood flow due to contrast injection during the time
period that FPA flow measurements were made.
To determine the required injection rate for complete replacement of
blood with contrast material, an ROI was positioned on the proximal
segment of the LAD. The volume of the contrast material enclosed in the
ROI was used to generate contrast pass curves for different injection
rates. An example of a contrast pass curve is shown in Fig 9
. The maximum of the contrast pass curve for different
injection rates is shown in Fig 10
. The contrast volume
for different injection rates indicates that an injection rate of
2
mL/s is adequate for complete replacement of blood with contrast
material for baseline.
|
|
The change in coronary blood flow for different injection rates
is shown in Fig 11
; there is only a small change in
coronary blood flow during the time period used for the FPA
flow measurement. The overall effect of contrast injection on
coronary blood flow was determined with ultrasound flow probe
data (Fig 12
). The mean coronary blood flow
rates before contrast injection (B) and during the FPA flow
measurement (D) time interval were related by
D=1.15B+1.82 mL/min (r=.94). These
measurements were made with standard injection rates of 2 and 4 mL/s
for baseline and maximum hyperemia, respectively.
|
|
| Discussion |
|---|
|
|
|---|
Angiographic methods for measuring coronary blood flow, using the FPA algorithm, have been reported.26 38 Marinus et al26 used the measured volume of the entrance arterial segment for blood iodine calibration. Hangiandreou et al38 used a pump to directly infuse contrast with known iodine concentration into the coronary artery. The limitations of these two techniques include x-ray scatter- and veiling glare, videocamera lag, blood iodine concentration measurement, determination of arterial segment volume, change in coronary blood flow due to contrast injection, and motion misregistration artifacts. These limitations have been addressed in the present study with the use of FPA algorithm in conjunction with dual-energy digital subtraction angiography.
It is well known that x-ray scatter- and veiling glare are two of
the major sources of nonlinearities in videodensitometric iodine
quantification using image-intensifier/television systems. A
convolution filtering method to estimate x-ray scatter- and veiling
glare has been reported.39 It was shown that scatter- and
veiling glare in humanoid phantom and animal images can be estimated
with a root-means-squared error of
8%. This technique does
not require sampling of scatter- and veiling glare intensity for each
study. It is estimated with image gray level and the readily available
x-ray beam parameters.
Previous reports have indicated that videocamera temporal lag causes a systematic underestimation in flow measurements38 and a significant reduction in dual-energy signal.40 As a solution to the significant limitations of the videocamera, with Plumbicon pickup tube, it was replaced with a charge-coupled device camera.40 This camera eliminates the systematic underestimation in flow measurement because it does not have any temporal lag.30 Furthermore, it reduces the possibility of misregistration artifacts in dual-energy images because the low- and high-energy images can be acquired at only 5 milliseconds apart.40
The lack of knowledge regarding blood iodine concentration, after contrast injection, has been another limitation in volumetric coronary blood flow measurement. Two different methods of estimating blood iodine concentration have been reported.26 30 In the first method, referred to as the entrance vessel technique, measured volume of a segment of the entrance vessel was used for calibration purposes.26 In the second method, referred to as videodensitometric calibration technique, it is assumed that blood is momentarily replaced with contrast material.30 The advantage of the entrance vessel technique is that it does not require power injection of contrast material. Its disadvantages are the uncertainties involved in measuring the volume of the entrance arterial segment. The volume is calculated from measured diameter with an edge-detection algorithm and the measured length of the arterial segment. There are significant limitations in quantifying cross-sectional area along the length of an arterial segment.37 Also, orthogonal projections are required for measurement of the arterial length. Another complicating factor is the three-dimensional motion of coronary arteries. The advantages of the videodensitometric calibration, used in this study, include the fact that it does not require the measurement of the entrance vessel volume. Its disadvantage is the requirement of power injection to ensure the complete replacement of blood with contrast material.
Power injection of contrast into a coronary artery produces a
back pressure that momentarily prevents blood from entering the
coronary artery.37 The magnitude of the generated
back pressure depends on the injection rate, the ratio of vascular and
aortic resistances, and vessel compliance. The results based on the
required injection rate for complete replacement of blood with contrast
material indicate that a standard injection rate of 2 and 4 mL/s was
adequate for baseline and maximum hyperemia, respectively
(see Figs 10
and 12
).
Another important factor in coronary blood flow measurement is
the significant perturbation in coronary blood flow after
contrast injection.31 With this technique, flow
measurements were made during contrast injection and completed within 3
seconds after the start of contrast injection. During this time
interval, there is only a slight elevation in coronary blood
flow, which is caused by the local increase in pressure (see Fig 11
).
Therefore, the flow measurement is completed before the onset of
significant changes in coronary blood flow. The magnitude of
the elevation in coronary blood flow during contrast injection
is influenced by the position of the catheter and whether it has side
holes.41 42 The increase in flow is more significant
during maximum hyperemia, where the vascular resistance is at
its minimum. On the other hand, the elevation in flow is eliminated in
the presence of a tight stenosis. The average overestimation in
coronary blood flow for different flow conditions was 15% (see
Fig 12
). As the results in Fig 11
show, the overestimation in blood
flow can be minimized when the catheter is carefully positioned in the
left coronary ostium. In cases where the tip of the catheter is
inside the left main coronary artery, the flow is further
elevated during contrast injection.
With the technique that we present, which is the combination of
motion-immune dual-energy digital subtraction angiography with
the FPA algorithm, absolute volumetric coronary blood flow can
be measured accurately. Fig 7
is an example of phasic coronary
blood flow measurement with use of this technique. The noise in
instantaneous blood flow measurement limits the measurement of phasic
coronary blood flow. However, it is possible to accurately
measure mean coronary blood flow with this technique (see Fig 8
).
The present results demonstrated the feasibility and potential utility of the FPA algorithm in conjunction with motion-immune dual-energy digital subtraction angiography for measuring volumetric coronary blood flow. Quantification of coronary blood flow will be useful for evaluation of the functional significance of stenosis and the effects of interventional procedures on absolute blood flow. The technique can be implemented in available angiographic systems. Flow measurements can be made in conjunction with routine angiography that is performed for assessment of vessel anatomy. Therefore, both anatomic and physiological information can be derived from the same images.
Clinical Implications and Limitations
For clinical use, our technique has some important limitations.
One potential limitation is that flow measurements have to be made
before contrast starts exiting the vascular bed. Also, diluted contrast
material cannot enter the vascular bed during this time interval.
However, all of the flow measurements in the present study were
made before coronary sinus opacification, which indicates that
the LAD vascular bed empties sufficiently slowly to allow the flow
measurements to be performed. Also, an injection time of 3 seconds was
adequate to ensure that only undiluted contrast material was entering
the vascular bed during the flow measurement time interval.
Overlapping of vascular beds from multiple vessels is another potential limitation of this technique. This problem is an inherent limitation of the projection nature of radiographic images. However, it is possible to choose an imaging projection that will minimize potential errors due to overlapping vascular beds.
The application of this flow measurement technique for determination of stenosis severity is limited when collateral blood flow is present. However, clinically, the situations most likely to involve collateral flow are those in which lesion severity is reliably assessed by angiography (eg, >90%). For less severe stenosis, for which angiographic assessment is less reliable, the frequency of appreciable collateral flow is markedly reduced.
Our current implementation of this technique uses dual-energy subtraction angiography that would require some modification for use with the existing cardiac catheterization x-ray equipment. However, this technique can also be implemented with phase-matched diastolic time subtraction images during a breath hold. The flow measurements can be completed within approximately four cardiac cycles, which reduces the possibility of motion misregistration artifacts compared with other techniques requiring temporal subtraction images during approximately 15 to 20 heart beats.20
Our technique offers the ability to compare resting or maximal myocardial blood flow before and after an appropriate intervention such as angioplasty or bypass surgery. However, a limitation of volumetric blood flow measurement in a coronary artery is that it does not account for the size of the vascular bed that is being perfused; that is, it is necessary to know the mass of the perfused muscle to determine whether a single measured maximal myocardial blood flow is normal. A previous study has shown that the regional myocardial mass was linearly related to the sum of coronary artery branch lengths distal to any point in the coronary artery tree.43 44 Therefore, it is possible to use the branch length information from the arteriogram for determination of myocardial mass. The volumetric blood flow measurement can be combined with the estimated myocardial mass to calculate myocardial perfusion. Thus, despite potential clinical limitations, results of the present study contribute to the understanding of the angiographic methods used for coronary blood flow measurement and show that this videodensitometric technique can potentially be used for quantification of myocardial perfusion during routine coronary arteriography.
| Acknowledgments |
|---|
| Footnotes |
|---|
| Appendix 1 |
|---|
|
|
|---|
![]() | (1A) |
where µ is the viscosity of the fluid, r is the
inner radius of the vessel, and L is vessel length. With an
assumed flow rate of Q (cm3/s), the
pressure drop across the cylindrical vessel can be expressed as the
following:
![]() | (2A) |
After the simplifying assumption is made that the single value
Rbed can be used to reflect the vascular
resistance of a nonstenotic vessel, flow can be expressed
as the following:
![]() | (3A) |
where Pa is aortic pressure, Pv is venous pressure, and RBbed is the vascular resistance for blood flow. After contrast injection, blood is temporarily displaced by contrast. This results in an increase in Rbed because µcontrast>µblood.
A single proximal stenosis adds a further complication
because there is an additional pressure drop across the
stenosis,
Ps. The pressure
drop across the stenosis,
Ps,
can be expressed in terms of flow, Q, with the following
quadratic expression11 :
![]() | (4A) |
where:
![]() |
and
![]() |
In the above equation, a is the viscous resistance
previously defined and b is the pressure drop due to exit
separation losses. The expression for b contains the fluid
density
, the normal cross-sectional area
An, and stenotic
cross-sectional area As of the vessel. The
pressure drop across the stenosis,
Ps, through the a and
b terms, also depends on the physical characteristics of the
fluid. Therefore, an increased pressure drop occurs across a
stenosis for a higher viscosity fluid such as contrast media.
This leads to decreased coronary blood flow.
Although the above simple model neglects several important factors, it
is a useful aid in understanding the changes in coronary blood
flow after injection of contrast media. During contrast injection,
there is a local increase in arterial pressure that is
dependent on many parameters, including the injection rate
and viscosity of the contrast material. Proximal to the injection site,
flow decreases and may actually reverse. The elevated downstream
pressure causes an increase in blood flow into the
peripheral vascular bed until contrast material has reached
the arterioles, which provide the main resistance to flow (see
Equations A1
and A3
). At the end of the injection, pressure in the
artery rapidly drops to the preinjection levels. However, the presence
of the high viscosity contrast material in the artery and resistance
vessels causes a drop in flow below control levels until the contrast
material is washed out of the resistance vessels. The degree of this
flow reduction is primarily influenced by the volume and concentration
of contrast material.31 Next, as the distal bed dilates in
response to the reduction of flow, Rbed reduces
and the flow increases. After the contrast has passed through and blood
flow resumes, the flow peaks before returning to the baseline flow as
Rbed returns to its resting value.
This discussion does not include other physiological factors, such as osmolarity, that have been reported to cause a reduction in flow. However, the general behavior of coronary blood flow after contrast injection appears to be predicted based on viscosity alone. Furthermore, in vitro and in vivo studies have shown that when the injected solution viscosity exceeds the viscosity of the perfusion media, the flow occurring immediately after the injection decreases below control levels.45 Also, it has been found that the use of nonionic contrast material decreases the magnitude of the later hyperemic response but has little effect on the severity of the flow reduction compared with ionic contrast material.46 This is consistent with the fact that both ionic and nonionic contrast materials also have high viscosity.
Received September 5, 1995; revision received October 30, 1995; accepted November 5, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Molloi, G. S. Kassab, and Y. Zhou Quantification of Coronary Artery Lumen Volume by Digital Angiography: In Vivo Validation Circulation, November 6, 2001; 104(19): 2351 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abaci, A. Oguzhan, N. K. Eryol, and A. Ergin Effect of Potential Confounding Factors on the Thrombolysis in Myocardial Infarction (TIMI) Trial Frame Count and Its Reproducibility Circulation, November 30, 1999; 100(22): 2219 - 2223. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||